You are here
AERIS THERAPEUTICS, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Pneumoreductive Surfactant Therapy for Emphysema
Amount: $855,484.00DESCRIPTION (provided by applicant): Aeris therapeutics is developing a novel medical treatment for patients with advanced emphysema known as Pneumoreductive Surfactant (PRS). PRSs are inhaled drugs ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
Enzymatic Pleurodesis for Malignant Pleural Effusions
Amount: $100,000.00DESCRIPTION (provided by applicant): This Phase I SBIR application is presented by Aeris Therapeutics, Inc. of Woburn, MA. It will examine the feasibility of using a novel enzyme based-system to p ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Pneumedoreductive Surfacant- New Therapy for Emphysema
Amount: $95,000.00DESCRIPTION (provided by applicant): This Phase I SBIR application is presented by Bistech, Inc. of Woburn, MA. It will test the feasibility of using a new inhaled pharmaceutical agent, pneumoreductiv ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health